Net Cash Provided by (Used in) Financing Activities of Alzamend Neuro, Inc. from 30 Apr 2020 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Alzamend Neuro, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Apr 2020 to 31 Jul 2025.
  • Alzamend Neuro, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Jul 2025 was $4,035,000, a 105% increase year-over-year.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $10,440,796, a 186% increase from 2023.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3,652,425.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $200.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Alzamend Neuro, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $4,035,000 +$2,071,356 +105% 01 May 2025 31 Jul 2025 10-Q 10 Sep 2025 2026 Q1
Q2 2024 $1,963,644 01 May 2024 31 Jul 2024 10-Q 10 Sep 2025 2026 Q1
Q2 2021 $14,911,556 +$14,834,546 +19263% 01 May 2021 31 Jul 2021 10-Q 13 Sep 2022 2022 Q1
Q2 2020 $77,010 01 May 2020 31 Jul 2020 10-Q 13 Sep 2021 2022 Q1

Alzamend Neuro, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $10,440,796 +$6,788,371 +186% 01 May 2024 30 Apr 2025 10-K 22 Jul 2025 2025 FY
2023 $3,652,425 +$3,652,225 01 May 2023 30 Apr 2024 10-K 22 Jul 2025 2025 FY
2022 $200* -$18,854,789 01 May 2022 30 Apr 2023 10-K 30 Jul 2024 2024 FY
2021 $18,854,989 +$14,404,892 +324% 01 May 2021 30 Apr 2022 10-K 27 Jul 2023 2023 FY
2020 $4,450,097 +$2,161,628 +94% 01 May 2020 30 Apr 2021 10-K 19 Jul 2022 2022 FY
2019 $2,288,469 01 May 2019 30 Apr 2020 10-K 29 Jul 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.